Search
for

    GlossaryCastration-Resistant Prostate Cancer

    cancer that grows despite low testosterone levels

    Castration-Resistant Prostate Cancer (CRPC) is a type of prostate cancer that continues to progress despite the reduction of testosterone to very low levels, typically achieved through medical or surgical means (castration). This form of cancer is particularly challenging to treat because it no longer responds to therapies that lower testosterone, a hormone that usually fuels prostate cancer growth.

    Related Terms

    Learn

    5 / 801 results

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors

      learn Cyproterone

      a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

      learn Pyrilutamide

      highly targeted anti-androgen that might have minimal systemic effects

      learn RU58841

      a potent but unapproved and potentially problematic topical anti-androgen

      learn GT20029

      research compound made to degrade androgen receptors in scalp

    Research

    5 / 1000+ results

    Community Join

    5 / 159 results